Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Rebright Partners Pte Ltd. is an early-stage venture capital firm established to support technology startups across Asia. Founded with backing from prominent Japanese corporate and institutional investors, the firm aims to facilitate the expansion of startups into Southeast Asia, India, and Japan. Rebright Partners operates from offices in Tokyo, Bengaluru, and Singapore, leveraging its extensive network to provide strategic support to its portfolio companies.
The firm has a strong focus on early-stage investments, particularly in the pre-seed, seed, and seed-plus stages. Rebright Partners has successfully built a portfolio of 47 companies, showcasing its commitment to fostering innovation in various sectors. Notable milestones include leading significant investments in companies like MediBuddy, Coins.ph, and Bukalapak, which have achieved substantial exits.
Rebright Partners invests in early-stage technology startups across multiple sectors, including healthcare, logistics, fintech, climate, and e-commerce. The firm primarily operates in Southeast Asia, India, and Japan, targeting startups at the pre-seed, seed, and seed-plus stages. Rebright Partners emphasizes digital transformation and aims to support startups that address social issues, particularly in India.
The firm seeks to partner with founders who demonstrate a strong vision and the potential for significant impact in their respective markets. Rebright Partners values innovative solutions that can scale effectively across borders, leveraging its extensive network to facilitate growth. The investment strategy includes a focus on sectors such as education and agriculture, aligning with the firm’s thesis of investing in technology that drives social change.
Rebright Partners has built a diverse portfolio of 47 companies, with notable investments including:
These companies reflect Rebright Partners' commitment to investing in technology that addresses critical needs in healthcare, logistics, and beyond.
Takeshi Ebihara: Founding General Partner / CEO. He has over 30 years of experience in venture capital and entrepreneurship, with a notable profile in Bloomberg.
Brij Bhasin: Partner. Brij brings extensive experience in venture capital and has been involved in several successful investments across Asia.
Mahesh Kumar: Principal. Mahesh focuses on sourcing and evaluating investment opportunities in the technology sector.
Hidemasa Ikeda: Principal / Executive Officer, Head of Japan. Hidemasa leads the firm's efforts in Japan, leveraging his deep understanding of the local market.
Hammad Maddekar: Senior Associate. Hammad supports the investment team in due diligence and portfolio management.
Ryunosuke Tanioka: Associate. Ryunosuke assists in research and analysis of potential investments.
Sachie Shigematsu: Associate. Sachie focuses on market research and deal sourcing.
Satoshi Nambu: Associate. Satoshi contributes to the evaluation of investment opportunities across various sectors.
Yuma Nakada: Associate. Yuma supports the team in operational aspects of portfolio management.
To pitch Rebright Partners, founders should submit their proposals through the contact page on their website. A concise pitch deck is recommended, highlighting the business model, market analysis, and team qualifications. While warm introductions are preferred, they are not strictly necessary. Founders can expect a response within a few weeks, depending on the volume of inquiries.
As of April 30, 2025, Rebright Partners made its latest disclosed investment in Stimuler, a seed-stage company. This investment reflects the firm's ongoing commitment to supporting early-stage technology startups in Asia.
In the previous year, Rebright Partners led a $22M Series B investment in Dat Bike, a Vietnamese electric vehicle company, showcasing its active involvement in the growing EV sector.
Rebright Partners has a history of notable exits, including MediBuddy, which achieved unicorn status, and Coins.ph, which was acquired. Bukalapak, another portfolio company, successfully went public, further highlighting the firm's successful investment track record.
What are Rebright Partners' investment criteria?
Rebright Partners focuses on early-stage technology startups in Southeast Asia, India, and Japan. They look for companies in sectors such as healthcare, logistics, fintech, climate, and e-commerce. The firm typically invests at the pre-seed, seed, and seed-plus stages.
How can I pitch to Rebright Partners?
Founders can reach out to Rebright Partners through their website's contact page. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential. Warm introductions are preferred but not mandatory.
What makes Rebright Partners different from other VCs?
Rebright Partners distinguishes itself through its strong backing from Japanese corporate and institutional investors, which enhances its capacity to support startups in Asia. The firm also emphasizes digital transformation and social impact, particularly in India.
What is the typical check size for investments?
While specific check sizes are not publicly disclosed, Rebright Partners typically invests in the range of $300K to $1.5M at the seed stage, based on their fund sizes and investment history.
What is the geographic scope of Rebright Partners?
The firm primarily focuses on Southeast Asia, India, and Japan, leveraging its extensive network to facilitate cross-border expansion for its portfolio companies.
What kind of post-investment support does Rebright Partners provide?
Rebright Partners adds value through strategic guidance, operational support, and facilitating connections within its network. The firm is actively involved in helping startups scale and navigate challenges in their respective markets.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.